CYTK

Cytokinetics Stock Analysis

AI Rating

Good
  • Quality5/10
  • Growth↓ 2/10
  • Momentum↑ 8/10
Cytokinetics sales and earnings growth
CYTK Growth
Fair
  • Revenue Y/Y↑ 2609.26%
  • EPS Y/Y↓ -16.91%
  • FCF Y/Y↓ -11.38%
Cytokinetics gross and profit margin trends
CYTK Profitability
Good
  • Gross margin ↑ 100.00%
  • EPS margin↓ -862.20%
  • ROIC↓ -36.10%
Cytokinetics net debt vs free cash flow
CYTK Risk
Great
  • Debt / Equity↓ -2.3
  • Debt / FCF↓ 2.1
  • Interest coverage↓ -17.7

Cytokinetics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗